Contact Us

Web Copyright: Shijiazhuang No.4 Pharmaceutical Co., Ltd.    Powered by   冀ICP备05007979号-1

Add: No. 288,Zhujiang Road, High-tech Industrial

Development,Shijiazhuang, Hebei, China
Tel: 86 311 67167137 / 67167144
E-mail: /
Skype: xlmamary

About Us

Contact us!

Online Message

Levofloxacin Injection / infusion


Product name

Levofloxacin Injection / infusion

Th e product is indicated for the moderate and severe infection caused by some sensitive bacteria
I want to make an inquiry
Product description
Levofloxacin Lactate Injection

Name: Levofloxacin Lactate Injection
Composition: The main composition of this product is levofloxacin lactate
Formula: C18H20FN3O4·C3H6O3·1/2H2O
Molecular weight: 460.41
Characteristic: The product is slightly yellow-green transparent solution.
 e product is indicated for the moderate and severe infection caused by the following sensitive bacteria:

Used to treat the following infections caused by the sensitive bacteria:
Respiratory tract infections, including bronchitic and pneumonia caused by the sensitive G- .
Urinary tract infections, including simple and complicated urinary tract infections and Pyelonephritis and etc.
Reproductive System Infection: acute prostatitis, acute epididymitis, uterine infection, adnexitis, pelvic inflammation.
Skin & soft tissue infection, cellutitis, lymphangitis, subcutaneous abscess, perianal abscess and etc.
Gastrointestinal infections, including bacillary dysentery, infectious enteritis, salmonella enteritis, typhia and paratyphoid and etc.
General infection including blood poisoning
Other infections: such as mastitis, trauma infection, burn wound infection, infection after surgery, abdominal infection, cholecystitis, cholangitis, bone and joint infection and etc.

Shijiazhuang No.4 Pharmaceutical Co., Ltd. was established in 1948, now it is a large-sized foreign invested enterprise and comprehensive medicine manufacturer in China, the capital is USD58 million, and with more than 3000 employees. The company can manufacture 7 series medicines of more than 100 kinds and specifications including infusions, capsules, granules, tablets, oral liquids and etc with GMP approval by SFDA of China. For the key product of large volume I.V solution, the yearly output has reached more than 1200 million bottles including 40 million bottles packing with the soft plastic bottles in the dosage of 500 ml/ 250 ml /100ml. Some index such as quality, variety, and yearly output are all in the leading position of this field in China.  

The products have been sold to some countries and regions in South America, Africa, and Asia.

Corresponding parameter set not found, please add it in property template of background